Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach: Om Mitta S et al.

Background: In essential tremor and Parkinson disease (PD) tremor, administration of onabotulinumtoxinA via a fixed injection approach improves the tremor, but many patients (30%-70%) develop moderate to severe hand weakness, limiting the use of onabotulinumtoxinA in clinical practice. …

Mayo Clin Proc.  XXX 2017; :1-9
 http://dx.doi.org/10.1016/j.mayocp.2017.06.010www.mayoclinicproceedings.org
 2017 Mayo Foundation for Medical Education and Research
Downloaded for Anonymous User (n/a) at University Of Texas Southwestern Medical Center At Dallas from Clinical Key.com by Elsevier on August 11, 2017. For personal use only. No other uses without permission. Copyright ©2017. Elsevier Inc. All rights reserved.
 
Autoren:

Shivam Om Mittal, MD; Duarte Machado, MD; Diana Richardson, MD; Divyanshu Dubey, MD; and Bahman Jabbari, MD

 

 

Autoren-Details:
From the Department of Neurology, Mayo Clinic, Rochester, MN (S.O.M.,D.D.); and Department of Neurology, Yale University School of Medicine, New Haven, CT (D.M.,D.R., B.J.)